You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis
|
|---|---|
| Published in |
BMC Musculoskeletal Disorders, January 2013
|
| DOI | 10.1186/1471-2474-14-13 |
| Pubmed ID | |
| Authors |
Sang-Cheol Bae, Suk Chyn Gun, Chi Chiu Mok, Rezaul Khandker, Henk W Nab, Andrew S Koenig, Bonnie Vlahos, Ron Pedersen, Amitabh Singh |
| Abstract |
Patient reported outcomes (PROs) are especially useful in assessing treatments for rheumatoid arthritis (RA) since they measure dimensions of health-related quality of life that cannot be captured using strictly objective physiological measures. The aim of this study was to compare the effects of combination etanercept and methotrexate (ETN + MTX) versus combination synthetic disease modifying antirheumatic drugs (DMARDs) and methotrexate (DMARD + MTX) on PRO measures among RA patients from the Asia-Pacific region, a population not widely studied to date. Patients with established moderate to severe rheumatoid arthritis who had an inadequate response to methotrexate were studied. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 50% |
| United States | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 148 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 20 | 13% |
| Student > Master | 19 | 13% |
| Student > Ph. D. Student | 16 | 11% |
| Researcher | 15 | 10% |
| Other | 14 | 9% |
| Other | 28 | 19% |
| Unknown | 38 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 54 | 36% |
| Psychology | 12 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 7% |
| Nursing and Health Professions | 11 | 7% |
| Social Sciences | 6 | 4% |
| Other | 12 | 8% |
| Unknown | 44 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2013.
All research outputs
#14,741,936
of 22,691,736 outputs
Outputs from BMC Musculoskeletal Disorders
#2,285
of 4,027 outputs
Outputs of similar age
#176,203
of 282,035 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#55
of 102 outputs
Altmetric has tracked 22,691,736 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,027 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,035 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.